© Copyright Nostre Net
Market Scope
The tenecteplase
drug market Share is expected to reach USD 2,455.4 million by 2030 at 5.10%
CAGR during the forecast period 2022-2030.Tenecteplase drug refers to a
recombinant enzyme that acts as a blood thinning agent. Also known as a clot
buster, tenecteplase drug helps dissolve blood clots or clumps, allowing the
blood to flow normally. These drugs are generally used for treating patients
facing heart-related issues.
Some of the leading factors influencing the market growth
include the increasing number of hypertension patients, rising number of deep
vein thrombosis cases, early aging, and sedentary lifestyles that lead to blood
clotting. The American Heart Association reported in 2017 that every 40
seconds, an individual in the United States (U.S) gets a heart attack.
Additionally, the report states that coronary heart disease
(CHD), which accounts for 43.8% is the main cause of deaths due to
cardiovascular disease (CVD) in the United States (US). Whereas, heart failure
(HF) (9.0%), high BP (9.4%), stroke (16.8%), and other CVDs (17.9%) are other
causes for deaths in the country. Furthermore, the report expects that by 2035,
over 130 million adults in the US, around 45.1%, will suffer from some form of
CVD. As a result, the overall costs of CVD are estimated to touch the valuation
of USD 1.1 trillion by 2035. Therefore, the hike in the rate of cardiovascular
diseases is projected to stimulate the tenecteplase drug market growth in the
years ahead.
Market Segmentation
The worldwide tenecteplase
drug market outlook has been segmented on the basis of application, dosage,
and end users.
The tenecteplase drug market, with respect to application,
is considered for myocardial infarction, stroke, DVT.
As per dosage, tenecteplase drug market can be broken down
into intravenous dosage and intracatheter instillation dosage.
The end-users in the market are hospitals and clinics,
surgical centers, research centers.
Regional Insight
The key markets for tenecteplase drug include Europe, Asia
Pacific, the Middle East, and Africa and North America.
North America has been estimated as the biggest market for
tenecteplase drug, on account of the rising innovations in clinical practice
and surge in myocardial infection. The region also benefits from increasing
access to stroke treatment, supported by the sophistication of healthcare
infrastructure in the region. An article by CDC in 2015 suggested that in the
United States (U.S.), close to 350,000 to 900,000 cases of Venous
thromboembolism (VTE) are estimated annually. These statistics point towards
the high potential of the tenecteplase drug market in North America.
Europe is the second most profitable market for tenecteplase
drug, with the chief reason being the increase in incidents of stroke. The
United Kingdom (UK) Organization has identified stroke as the 10th primary
cause of death globally, with 34,883 mortality cases found in the UK alone in
the year 2015. As a result of a surge in hypertension as well as high blood
pressure, the stroke cases are on the rise in the region, elevating the market
position of tenecteplase drug.
Key Companies
The key companies present in the worldwide tenecteplase drug
market include Genentec Inc., Gennova pharmaceutical, Merck Ltd., Hisun USA,
Boehringer Ingelheim International GmbH, Crunchbase Inc., Rewine
pharmaceuticals, Emcure Pharmaceutical, and others.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
Healthcare research and the high demand for
food are key areas where next-generation sequencing is being used extensively.
Increasing genetic disorders are being diagnosed which has drastically
increased the demand for next-generation sequencing. Moreover, the use of this
technology in drug discovery is significant and expected to drive growth as the
demand for effective drug therapies increases.
Increasing awareness, employment of various
growth strategies and ongoing technical advancements are expected to provide
the market with ample opportunity for growth. However, the high initial cost of
implementing technologies, and the requirement for storage of large volumes of
data as well as a lack of skilled workforce to run the technology are
challenges to the growth of the Next Generation Sequencing market.
global Next-Generation
Sequencing Market trends is expected to increase value of USD 10300 million
during the projected quarters of 2022-2030, The market is estimated to grow at
11.5% CAGR by 2030. Also known as massive parallel sequencing or high
throughput sequencing technology, next-gen sequencing has been transformative
for the field of genomic research as it allows the sequencing of a complete
human genome in a very short amount of time. During the process, the genetic
material is extracted, fragmented, and associated with various factors for
amplification. As such, this technology is highly effective and advanced thus
driving its adoption and growth. The improved speed and reduced costs are
expected to drive market growth. Use in clinical applications, agricultural
applications, and forensic applications are growing rapidly.
DNA technology has come a long way, and
next generation sequencing is expected to take DNA technology further than ever
before. Market Research Future's report on the global next-generation
sequencing market divulges key details regarding the growth of the market as
well as various vital facts, figures, and prediction of growth of the global
market.
Market Segmentation
Analysis of the markets several parts are
included in MRFR's segmental analysis which has been performed on the basis of
technology, service & product, application, end-user, and region.
The technology used in next-generation
sequencing includes whole exome sequencing, CHIP sequencing, whole genome
sequencing, methyl sequencing, targeted resequencing, de novo sequencing, and
RNA sequencing, next generation sequencing data analysis.
By service & product, the next
generation sequencing market has been segmented into consumables, sample
preparation, platforms & services for platforms, and sequencing services.
The sample preparation segment is further divided into end repair, A-tailing
& size selection, quality control, library preparation & target
enrichment, and DNA fragmentation. Other sub-segmentations have been mentioned
and expounded on in the report.
Applications of next-generation sequencing
include genetic screening, drug discovery, diagnostics, agriculture &
animal research, and others.
End-users of next-generation sequencing
include hospitals & clinics, academic institutes & research centers,
pharmaceutical & biotechnology companies, and other end-users.
Regional Analysis
The global next
generation sequencing market research Report is segmented into key regions
which include the Americas, Asia Pacific, Europe, and the Middle East &
Africa. North America in the Americas region is slated to lead the market with the
largest share due to the high competition between market players in the region
as well as the rising demand for next-gen sequencing in the healthcare sector
of developed economies such as the US and Canada. Moreover, the presence of a
significant healthcare sector in the region combined with growing investments
in healthcare toward the development of therapies for chronic diseases will
push growth during the forecast period.
The European region has the second largest
market due to the significant R&D activities that take place in the region
with regards to various fields including healthcare. The presence of pioneering
next-gen sequencing technology market players are expected to make an impact on
the market. However, growth here is restrained due to regulations and
fragmentation of the market across Europe.
Key Players
Oxford Nanopore Technologies, Ltd., BGI,
Pacific Biosciences of California, Inc., PerkinElmer, QIAGEN N. V., Eurofins
Scientific, Agilent Technologies, Macrogen Inc, Illumina, Inc., and Thermo
Fisher Scientific, Inc. are among the notable market players that have been
included in MRFR’s competition tracking of the global next generation
sequencing market.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The cerebral
palsy market trends is anticipated to reach USD 3,287.51 Million by 2030 at
3.20% CAGR during the forecast period 2022-2030.
Cerebral palsy is defined as a group of
disorders that affect muscle movement and coordination, which in many cases,
impairs vision, hearing, sensation and others senses. Cerebral palsy is a
congenital disorder of movement, muscle tone or posture and can affect a
person’s posture, balance and ability to move, communicate, eat, sleep and
learn. According to the Centre for Disease Control 1 to 4 out of every 1,000
children across the globe are affected by cerebral palsy, thereby creating a
strong demand for dia gnosis, and treatment for the condition which will drive
growth for cerebral palsy market.
Competitive Overview:
Allergen Plc, Cellular Biomedicine Group,
Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline Plc, Abbott Laboratories,
Acorda Therapeutics, Inc., Medtronic, Meridigen Biotech Co., Ltd., GW
Pharmaceuticals Plc, and Cell Cure Neurosciences Ltd. are some of the key
players in the global cerebral palsy market.
Segmentation
The cerebral palsy market has been
segmented into type, diagnosis, and treatment.
On the basis of type, cerebral palsy market
has been segmented into hypotonic cerebral palsy, spastic cerebral palsy,
ataxic cerebral palsy, dyskinetic cerebral palsy, and mixed cerebral palsy.
By diagnosis, CP market segmentation
includes imaging tests and others. The imaging tests segment has been further
classified into computed tomography, magnetic resonance imaging (MRI), cranial
ultrasound, and electroencephalogram.
Based on treatment, cerebral palsy market
has been segmented into therapy, medication, surgery, cerebral palsy drugs and
others.
Regional Market Summary
Geographically, the Americas region is anticipated
to dominate the global cerebral
palsy market Report owing to a well-developed healthcare sector, rising
prevalence of cerebral palsy and growing healthcare expenditure. Additionally,
favorable reimbursement scenario in this region and a relatively large number
of research and development (R&D) activities contributes to the growth of
the market.
Europe is expected to hold the second
largest position in the global cerebral palsy market. The market growth in this
region is attributed to the growing prevalence of cerebral palsy, availability
of funds for research, and increasing healthcare expenditure. According to the
data stated by the National Institute for Health and Care Excellence (NICE) in
2017, in the UK, it is estimated that 1 in 400 babies are born with cerebral
palsy. It also stated that approximately 1,800 children diagnosed with CP each
year.
The cerebral palsy market in Asia-Pacific
region consists of countries namely China, Japan, Republic of Korea, India,
Australia and Rest of Asia-Pacific. Asia-Pacific is anticipated to be the
fastest growing region in the market due to the presence of a huge patient
population, continuously developing economies, rising prevalence of cerebral
palsy and increasing government funding for the healthcare sector.
On the other hand, the Middle East &
Africa has the least share of the market. Majority of the market of this region
is expected to be held by the Middle East region due to a well-developed
healthcare sector and growing government initiatives for the healthcare sector.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The global nutraceutical excipients
market trendsis growing
pervasively. The market growth is mainly driven by the burgeoning nutraceutical
sector. In 2017, the market had reached USD 3104.96 Mn and is expected to value
at USD 4818.70 Mn. by 2023. Excipients are inactive components added to
nutraceuticals during its production to help stabilize the ingredients.
Nutraceutical excipients perceive augmenting demand, which in turn,
substantiates its market size globally.
Hike in investment related to healthcare, transforming lifestyle
triggering various diseases, and others are major factors that can
significantly inspire the growth rate of the market. The growing awareness
among people regarding health benefits, an increasing number of products
entering the pipeline, and others can inspire the growth of the market. On the
other hand, stringent regulations can hold back the growth rate in the coming
years. But the market can bank on the developing technologies for better growth
assistance.
Competitive Landscape:
A lot of companies are
trying to make the market for the global nutraceutical excipients prosper with
high growth opportunities. These segments are known for extensive participation
in taking the market ahead. MRFR recorded their recent steps to gauge in which
direction the market is moving and find better growth possibilities there.
These companies are Ingredion, Cargill Corporation, Kerry, Sensient Technology
Corporation, Associated British Foods plc, JRS PHARMA, Roquette Freres SA,
DowDupont, Innophos, Inc., and Hilmar Ingredients.
Segmentation:
The global market for nutraceutical
excipients is set to find a segmentation in the report that would be based on
form, function, type, and application. These segments have a better acceptance
of various factors that can be taken into consideration to understand how the
market can chart the future path.
By function, the market for nutraceutical
excipients can be segmented into fillers, diluents & bulking agents,
disintegrants, binders, lubricants, sweeteners, coating agents, and colors
& flavors. The fillers, diluents & bulking agents have a chance to
expand at 8.34% CAGR during the forecast period.
By form, the market for nutraceutical
excipients can be segmented into liquid and dry. The former has a better market
share. It has a coverage of almost 55% of the global market. It had a market
valuation of USD 1 Bn in 2017. The dry segment can score a 7.34% CAGR during
the review period.
By application, the market for
nutraceutical excipients can be segmented into omega-3 fatty acids, proteins
& amino acids, probiotics & prebiotics, and vitamins & minerals. The
probiotics & prebiotics segment had the market command in 2017 when it had
coverage of 47.5% market share. Its CAGR would be impressive. However, the
vitamins & minerals segment has the chance for growth with a CAGR of 7.92% during
the forecast period.
By type, the market report
that includes nutraceutical excipients can be segmented into artificial and
natural/organic. The artificial segment had better market dominance in 2018.
But growing consumer awareness can inspire a better intake of the natural/organic
nutraceuticals products.
Regional Analysis:
The Americas have a high chance of contributing the
maximum revenues in terms of fetching from the profit. The regional market has
North and South America. North America includes the US and Canada where various
global nutraceutical
excipients market reportplayers are gaining hike from increasing chronic diseases, high
health-related investment, better awareness, assistance from various policies,
and others are expected to create better provision for the global market.
Various changes in the lifestyle have influenced a hike in various diseases
like diabetes, respiratory issues, and others. The market in Europe is expected
to establish itself as the second-best market. Its resemblance to North America
can inspire better market growth. Health cost expenditure in the region is
quite high owing to which the market can witness better growth. Its intake as a
preventive measure is quite high in the region.
The market in Asia-Pacific has potential as the
region has several developed and fast-developing countries. For instance,
markets like Australia, Japan, India, China, and South Korea can inspire the
global market to register the fastest CAGR in the coming years. The market
would benefit from a large number of consumers as well.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of
various industries through Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and
Market Research & Consulting Services.
Optical imaging refers to a technology that holds great
potential to improve the mode of treatment, disease diagnosis, and prevention
in the hospital operating room. This technology offers a host of benefits
compared to radiological imaging techniques. Optical imaging technique makes
use of non-ionizing radiation and reduces the patient’s radiation exposure,
which gives way to numerous studies over time. It also helps differentiate soft
tissues from native soft tissues or the tissues that posses exogenous or
endogenous contrast media using various photon absorption profiles at different
wavelengths. Optical imaging is a highly responsive imaging technique which can
be used by easily combining it with other imaging techniques.
The optical
imaging market trends is expected to be of value USD 3.44 billion in 2030
and to grow at a 9.7% CAGR during the forecast 2022-2030.
Pharmaceutical and biomedical industries make heavy demand
for radiation-free imaging techniques, which accelerates the popularity of
optical imaging. Surging prevalence of neurological as well as ophthalmological
disorders among the worldwide population could accelerate demand for imaging
diagnosis, thereby elevating market growth. Technological advancement coupled
with increasing government support that benefits the healthcare industry paves
the way for several growth opportunities.
Some other growth-inducing factors driving market growth
include quick adoption rates of technically advanced devices, highly-developed
research infrastructure, and growing number of skilled professionals.
Technological advancement has led to complete transformation of medical
science, where optical imaging stands as the most affected aspect. This has
revolutionized the healthcare industry by increasing the ability to detect a
higher number of diseases.
Market Segmentation
The worldwide market for optical imaging has been segmented
on the basis of products, techniques, therapeutic area, application, and
end-user.
With respect to the type of product, the market comprises
imaging systems, software, lenses, illumination systems, cameras, and others.
Imaging systems can be sub-segmented into optical imaging systems and spectral
imaging systems.
Technique-wise, the market covers optical coherence
tomography (OCT), photoacoustic imaging, diffused optical tomography,
hyperspectral imaging, near-infrared spectroscopy, and super-resolution
microscopy.
Depending on the therapeutic area, the market covers
oncology, ophthalmology, neurology, cardiology, dermatology, dentistry, and
others.
Considering the application, the market caters to
pre-clinical and clinical research, pathological imaging, and intraoperative
imaging.
The end-users in the market include hospitals and clinics,
diagnostic imaging centers, pharmaceutical &biotechnology companies, and
research laboratories.
Regional Insight
Based on the geographical distribution, the optical
imaging market research report has been studied in the primary regions of
Europe, the Americas, Middle East, and Africa and Asia Pacific.
The Americas has been identified as the largest market for
optical imaging. Rising prevalence of neurological, ophthalmic, and
cardiovascular disorders among the geriatric population triggers market growth
in the region. Moreover, a boost in the number of government initiatives along
with funding for research within the medical devices sector stimulates market
growth. Mounting demand for accurate diagnosis, high awareness regarding the
adverse effects of radiation imaging, and presence of highly regarded
pharmaceutical companies work in favor of the market. Also, vast patient pool
in the region is expected to augment market demand in the years to come.
Europe stands as the second leading market for optical
imaging. The robust share is the result of existence of advanced treatment
facilities, high healthcare expenditure, and well-developed healthcare
infrastructure. The flourishing medical device industry backed by the efforts
of prominent players adds to the market strength. Plus, rising knowledge with
regard to the benefits of optical imaging compared to radiation imaging spurs
the market growth in the region.
Asia Pacific could expand at the fastest rate, holding the
most promising growth prospects. A 2014 report by the department of neurology
reveals that among the present population of 1.27 billion, close to 30 million
people are afflicted with neurological disorders only in India. Therefore, the
huge patient pool combined with the fast rate at the healthcare technology is
catching up, the regional market is bound to note excellent gains in the near
future. The region also benefits from various government initiatives that help
improve healthcare quality and the availability of favorable insurance
policies. Apart from this, the lower cost of clinical trials and several
research companies striving to set up their regional headquarters as well as
manufacturing plants in China, Singapore, Korea, Australia, and Japan could
mark an optimistic market outlook in the subsequent years.
Middle East & Africa could showcase poor growth in the
global market. The factors holding back the market include limited access and
availability of treatment facilities and lack of awareness. In the Middle East,
Saudi Arabia and the United Arab Emirates (UAE) account for the substantial
share in response to the steadily expanding healthcare industry and increasing
number of specialty care centers. Overall, the regional market could
demonstrate consistent growth soon owing to rising number of government
initiatives aimed at enhancing the quality of healthcare.
Renowned Companies
Some of the renowned companies shaping the worldwide optical
imaging market are Bioptigen, Inc., Agfa-Gevaert N.V., Perkinelmer, Inc., Carl
Zeiss Meditec AG, St. Jude Medical, Inc., Topcon Corporation, Heidelberg
Engineering, Inc., Canon Inc., Koninklijke Philips N.V., among others.
Industry Updates
A team of researchers at the University of Illinois have
developed a new type of portable optical imaging system that helps visualize
the fundamental cellular as well as molecular features in just removed breast
tissue specimens.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research
(CFR), and Market Research & Consulting Services.
The uptick in demand for nanotechnology practices that can
solve several genetic-related diseases has increased of late. The multiplex
assays market size is expected to reach USD 3.11 Billion an approximate
CAGR of 6.80% during the forecast period (2022-2030).The market for multiplex
arrays is advancing due to the increased funding and research being diverted to
the market. Increased awareness of the benefits of multiplex assays is fuelling
the growth of the market over the forecast period. The multifactorial nature of
several diseases and pathological conditions such as Alzheimer and cancer are
motivating the development of the market significantly.
Competitive Analysis
The notable contenders shaping the market development over
the forecast period are Illumina Inc, Bio Rad Laboratories Inc, Thermo Fisher
Scientific Inc, Qiagen, Abcam plc, BD, Agilent Technologies, Meso Scale
Diagnostics LLC, Merck Sharp & Dohme Corp, Quanterix, Bio-Techne, Randox
Detailed Regional Analysis
The North America region is accountable for the prime stake
of the market due to robust R&D activities in this region. The US is a
chief country in terms of biopharmaceutical research and development. The
important factors that drive the development of the market in this region are
the rise in-patient population, and the growing detection of Alzheimer disease,
and a substantial rise in research and development activities of the
pharmaceutical companies for the treatment of diseases such as cancer and
Alzheimer. The Asia Pacific is anticipated to record the highest CAGR during
the forecast period. Due to the increasing geriatric population, mounting
prevalence of cataract, and growing prevalence of Alzheimer disease in this
region. The European region is estimated to note a high CAGR during the
forecast period owing to the increasing geriatric population.
Segmental Analysis
The multiplex
assay market Outlook is segmented on the basis of types, application,
products and services, technology, and end-user. By products and services, the
market is segmented into instrument, consumable, and software and services.
Based on types, the market is segmented into nucleic acid, protein, and
cell-based multiplex assay. On the basis of technology, the market is segmented
into fluorescence detection, flow cytometry, luminescence, multiplex real-time
PCR, and other technologies. On the basis of application, the market is
segmented into clinical diagnostic, research and development, and other
diseases. By end user, the market is segmented into hospital and research institutes,
pharmaceutical and biotechnology companies, clinical laboratories, and other
end-users.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity
of various industries through Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and
Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Highlights
Facial paralysis is a restriction of the
facial movement due to nerve damage. Facial nerve paralysis is characterized by
unilateral facial weakness. Some other symptoms include loss of taste,
hyperacusis, and decreased salivation and tear secretion.
Asia Pacific is the fastest growing market
for facial paralysis whose growth is attributed to the rising population and
increasing standard of living. Additionally, the increasing healthcare spending
and the improved standard of living are likely to drive the growth of the
market. India and China are the major contributors to the market growth due to
the rapid development of healthcare infrastructure in these regions and the
increasing demand for diagnostic services.
The global facial
paralysis market Trends is expected to register a CAGR of 6.5% during the
forecast period.
Key Players
Some of the key players in the facial
paralysis market are, Boston Scientific, BioControl Medical, Cerebomed,
Cyberonics, Astellas Pharma Inc., Sucampo Pharmaceuticals, Inc., and Novartis
AG, among others.
On the other hand, the Middle East and
Africa is expected to witness a gentle growth due to limited access to the
healthcare industry and affordability issues among the population. In the
Middle East, the growth of the market is driven by the increasing availability of
new and advanced diagnostic and treatment methods for various chronic diseases.
Segmentation
The global facial paralysis market is
segmented on the basis of treatment, diagnosis, type, and end-user.
On the basis of type, the market is
segmented into, Ramsay Hunt Syndrome, facial erythema, Bell’s Palsy, and Lyme
Disease.
On the basis of diagnosis, the market is
segmented into electromyography, computerized tomography, and magnetic
resonance imaging.
On the basis of treatment, the market
is segmented into medications, physical therapy, and surgery.
On the basis of medication, the
market is further sub-segmented into corticosteroids and antiviral drugs.
On the basis of end-user, the market is
segmented into hospitals and clinics, specialty centers, and research centers.
Regional Analysis
The Americas dominates the global facial
paralysis market Research Report owing to increasing cardiovascular
disorders, which eventually leads to the increasing patient population.
Additionally, increasing cardiovascular disorder rate is likely to enhance the
growth of facial paralysis in the North American region. According to the
American Heart Association, 31% of the deaths in the U.S. were due to
cardiovascular disorders. Similarly, in 2015, around USD 3.2 trillion were
spend in healthcare expenditure in the U.S according to the Center for Disease
Control and Prevention. Similarly, in 2015, 1.3% of the U.S. adults were
diagnosed with inflammation of facial nerves.
Europe accounts for the second largest
market due to increasing cardiovascular disorders and increasing infections.
Additionally, the increasing government support and improving healthcare infrastructure
along with increasing facial inflammations are driving the growth of the facial
paralysis market in Europe. For instance, Eurostat estimated that over 19.2% of
the population in Europe was aged 65 and above. This increasing older
population is likely to lead to the increasing patient population. These
factors are likely to drive the growth of the facial paralysis market.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Gout
Market Overview and analysis By Type, By Treatment, By Diagnosis And By End-User Global Forecast Till 2030. The
gout market is anticipated to reach USD 4162.5 Million by 2030 at 11.75% CAGR
during the forecast period 2022-2030, which has been marked as the forecast
period by Market Research Future (MRFR) in the published report. The report
also includes several factors that can make sure the market would grow in the
coming years. Gout can be described as a type of arthritis, which is caused by
higher uric acid levels in the blood. The disease can be triggered by high
blood pressure, high cholesterol, and medications that can spike the presence
of uric acid in the blood. Obesity, diet containing a high amount of red meat,
consumption of alcohol and smoking can trigger symptoms of gout.
The market is getting better thrust from
factors like growing elderly population, transforming lifestyle that includes
more sedentary time, advents of better treatment facilities, and government
initiatives. However, lack of awareness can make this growth daunting in the
coming years.
Competitive Landscape:
The gout market is having a strong influx
of various new players who are giving tough competition to the existing market
bigshots. These players are launching their own types of market strategies to
make sure that they get good mileage from the market. Their strategic moves
often include mergers, new launches, acquisitions, investment, and others. MRFR
got these changes recorded in the report to get a closer view of how the market
is shaping up. These players are Savient Pharmaceuticals, Takeda Pharmaceutical
Company Ltd. Merck & Co. Inc., AstraZeneca plc, Astellas Pharma Inc.,
Ardelyx, Inc., and Novartis AG.
Regional Analysis:
The North American gout market has a
notable chance of making progress in the coming years. The regional market is
known for its high expenditure for the research and development sector, which
is triggering an increasing number of medicines that are getting launched every
year. Major countries inspiring changes are the US and Canada. The regional
number of smokers is also quite high, which, along with the high number of
geriatric population, can trigger the expansion of the gout market. High number
of obese people can also open up spaces for such diseases.
Europe’s market is the second-highest as
the regional awareness regarding gout-related problems is quite high. This is
getting fostered by the rising number of elderly people. Advanced treatment
facilities are also getting introduced owing to which a lot of people are
showing interest in getting their disease healed. This is also getting
bolstered by a rising amount of investment.
The Asia Pacific market is going to show
changes in the market as the growing awareness and the massive population is
expected to transform the market dynamics. The demographic conditions are also
going to play in favor of the market. Countries are launching extensive plans
for their healthcare sectors that can influence the gout market growth as well.
China would be the fastest-growing country. Transforming lifestyles are also
going to create space for market expansion.
The Middle East & Africa market may
suffer from the presence of poor economies, lack of awareness, and insufficient
backing from the technological setup. However, the scenario is changing in
countries like the UAE, Dubai, Saudi Arabia, Qatar, and others.
Segmentation:
The global gout
market research reports of MRFR suggests, can be studied on the basis of an
expert segmentation that includes end-user, treatment, type, and
diagnosis. The report focuses on achieving insights from the market and
that has initiated a detailed review of each segment.
By type, the report on the gout market can
be segmented into tophaceous gout and pseudogout. Both these segments are known
for their impact on the market and revenue-generation.
By treatment, the gout market report can be
segmented into medications and self-care. The medication segment includes
Probenecid, Allopurinol, Febuxostat, Diclofenac, Indomethacin, and Ibuprofen.
The self-care segment is getting acknowledged by patients across the world.
By diagnosis, the market report on the gout
industry can be segmented into blood tests, MRI, X-ray, ultrasound, urine test,
CT scan, and others. Growing demand for early diagnosis is expected to set up a
significant scope for these tests to fetch high income.
By the end-user, the market report on the
gout industry comprises specialty centers, hospitals, and homecare. The home
care segment is witnessing a surge as an increasing number of people are opting
for the self-care segment.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Mental health has come into focus due to
changing lifestyles of patients and unhealthy work hours. Mental health
software and devices utilizes the power of information technology to keep a
check on mental or behavioral disorders. The global mental health software and
devices market report by Market Research Future (MRFR) focuses on various
issues plaguing the market as well as efforts by manufacturers.
The mental
health software and devices market trends is expected to reach USD 17.2
Billion by 2030 at 16.1% CAGR during the forecast period 2022-2030
Market Outlook
due to the rapid adoption of software by
mental health professionals. Change in health practices due to availability of
patient records and mental health history can lead to effective management of
patients. Collection and analysis of information, elimination of errors, rise
in patient income levels, and demand for effective solutions for management of pharmacies
are mental health are other drivers of the market.
Development of wearables, changing
attitudes of patients and doctors towards information technology, and pressure
on hospitals to reduce operational costs can drive the global mental health
software and devices market. Real-time monitoring of patient health and
provision of advice and medicines via telemedicine can bode well for the market
growth in the coming years.
Competition Outlook
Prominent mental health software vendors
and device manufacturers profiled in the report include Athena Health,
Mindlinc, Mentegram, WRS Health, Kareo, Nextgen Healthcare, ICANotes, Core
Solutions, InSync Healthcare Solutions, Compulink, Allscripts, Nuesoft
Technologies, NextStep Solutions, Valant, Credible Behavioral Health,
Welligent, Raintree Systems, Netsmart, Meditab Software, Orion Health, The Echo
Group, Sigmund Software, IBM, TheraNest, Advanced Data Systems, AdvancedMD,
Qualifacts, McKesson Corporation, iSalus Healthcare, and Cerner Corporation.
Segmentation Analysis
the global mental health software and
devices market is segmented on the basis of solution, deployment, end users and
regions.
By component, the market has been segmented
by software and devices. The software has been sub-segmented into web based and
standalone software.
By functionality, the market has been
segmented by clinical, administrative, financial and others. The clinical
segment has been categorized into tele-health, electronic health records
(EHRs), E-prescribing, clinical decision support, health management, and
others. The administrative has been sub segmented into information management,
scheduling, workforce management, and others.
The financial has been sub segmented into
accounting, revenue cycle management, business intelligence, and others.
Regional Analysis
Region-wise, the global Mental
Health Software and Devicesmarket report comprises North America,
Middle East & Africa (MEA), Asia Pacific (APAC), and Europe.
North America accounted for the largest
market led by the U.S. due to focus on mental health by governments. According
to the American Psychological Association in 2019, the number of young U.S.
citizens with an increase of mental health disorders has risen due to shift in
mood disorders. Other drivers include rapid adoption of technology and
development of healthcare infrastructure by governments.
Europe is the second largest region of the
market driven by large number of burnout cases and mental health issues of
employees. Governments in the region have developed a common platform for
collection of mental health issues and records of patients for implementation
of good policies as well as welfare schemes. On the other hand, the APAC region
is expected to exhibit the fastest growth rate during the forecast period due
to being driven by economies of China, India, and Japan. International brands
in the region are giving mental health insurance for preventing burnouts and
reducing stress in the workplace.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Surgical devices are types of instruments
that are used for performing numerous forms of surgeries in accordance to the
complexity of the surgery like minimally invasive, open, or other types of
surgery. The General
Surgical Devices Market trends is anticipated to reach USD 15.1 Billion by
2030 at 8.60% CAGR during the forecast period 2022-2030.
As per the research conducted by Market
Research Future (MRFR), the market is identified to be influenced by numerous
factors. The high demand centered around disposable supplies like catheters,
syringes, and needles, the growing awareness concerning diseases being
transmitted through surgical forms of devices, and favorable government
regulations in ensuring or maintaining safety in surgical procedures are
expected to stimulate a positive demand for disposable products, thereby
pushing the overall general surgical devices market. An influx of global health
initiatives causing advancement in surgical procedures are expected to drive
the global general surgical devices market. However, factors like strict
government regulations in developing nations and improper reimbursement for
surgical devices can cause the market to falter in terms of growth.
Competitive Landscape
The global general surgical devices market
comprises of numerous players. A few of them identified in the report are 3M
Healthcare (U.S.), Johnson & Johnson Services, Inc. (U.S.), B. Braun
Melsungen AG (Germany), Grifols (Spain), SOFINA s.a (Biomérieux) (U.S.), Erbe
Elektromedizin GmbH (Germany), Integra LifeSciences (U.S.), Medtronic Plc.
(U.S.), Smith & Nephew (U.S.), Stryker Corporation (U.S.), Maquet Holding
B.V. & CO. KG. (Germany), CareFusion Corporation (U.S.), Becton, Dickinson
and Company (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Conmed Corporation
(U.S.), Accuray Incorporated (U.S), Boston Scientific Corporation (U.S.),
Ortho-Clinical Diagnostics, Inc. (U.S.), Intuitive Surgical Inc. (U.S.),
Siemens Healthcare GmbH (Germany), Cadence Inc. (U.S.), Thermo Fisher
Scientific, Inc. (U.S.), Virtual Incision Corporation (U.S.), Titan Medical
(Canada), Medrobotics Corporation (U.S.), TransEnterix Surgical (U.S.), Olympus
Corporations (U.S.), Verb Surgical (U.S.), Meere Company (U.S.), and others.
Market Segmentation
The global general
surgical devices market outlook segmentation is done on the basis of
application, type, product, and end-user.
By type, the market includes energy-based
and powered instrument, disposable surgical supplies, minimally invasive
surgery instruments, surgical instruments, medical robotics, open surgery
instrument, computer-assisted surgery devices, and others.
The disposable surgical supplies segment is
narrowed down into examination and surgical gloves, surgical non-woven, venous
access catheters, general surgery procedural kits, needles and syringes, and
others.
The surgical non-woven segment is broken
down into surgical drapes, disposable surgical masks, surgical caps, surgical
gowns, and others.
The open surgery instrument narrows down
into dilator, retractor, and catheters.
The energy-based and powered instrument is
divided into drill system and powered staplers.
The minimally invasive surgery instruments
segments into organ retractor and laparoscope.
The medical robotics and computer-assisted
surgery devices segment breaks down into adhesive prevention products and
others.
By product, the market includes
electrosurgical devices, trocars and access devices, handheld devices, wound
closure devices, laparoscopic devices, and others.
By application, the market comprises
thoracic surgery, ophthalmology, plastic surgery, orthopedic surgery,
cardiology, neurosurgery, audiology, into wound care, urology and gynecology
surgery, and others.
By end-user, the market includes research
centers, diagnostic centers, hospitals, academic institutes, clinics, and
others.
Regional Analysis
The global general surgical devices market
is geographically segmented across the following regions: Europe, America, Asia
Pacific, and the Middle East and Africa.
The Americas dominate the global market
with the highest share percentage and is expected to further maintain its
standings in the forthcoming years. This is due to the vast presence of key
players, a striking number of surgical procedures, favorable reimbursement
policies, and various initiatives undertaken by the government for providing
training sessions as well as access to advanced devices for physicians.
The Asia Pacific region is projected to
grow at the maximum pace during the forecast period owing to growing
investments alongside the regional expansion. The Middle East and Africa region
boasts the potential to emerge out as a big production hub for large-scale
development and medical devices. This is due to the low cost associated with
product development here in this region.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.